Resource Center

Your hub for insights, evidence, and expertise —
from peer-reviewed publications to practical solutions

Explore our latest insights, case studies, scientific publications, and more. Whether you’re looking for evidence of impact, thought leadership, or peer-reviewed research, this is your go-to hub for resources that reflect our commitment to advancing science, improving outcomes, and supporting our clients.

Browse a wide range of content including white papers, webinars, journal articles, conference presentations, and solution briefs – all developed in collaboration with our partners and backed by real-world experience.

Publications

Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations

19-Mar

Journal Article

Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study

Mar-24

Journal Article

Phase 2 Trial Evaluating Minocycline for Geographic Atrophy in Age-Related Macular Degeneration: A Nonrandomized Controlled Trial

Mar-24

Journal Article

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial

Apr-24

Journal Article

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adul

Mar-24

Journal Article

A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin(R)) Vaccine in Healthy US Adults

Mar-24

Journal Article

Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-Human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598

Apr-24

Journal Article

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Apr-24

Journal Article

Reply

Apr-24

Journal Article